UNSPSC 51283720: Cefotiam dihydrochloride

This classification denotes a cephalosporin antibiotic with the molecular formula C18H23N9O4S3.2ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H7V12WDZ93, chemically known as 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)acetyl)-amino)-3-(((1-(2-(dimethylamino)ethyl)-1h-tetrazol-5-yl)-thio)methyl)-8-oxo-, hydrochloride, (6r-trans)-, but more generally known as cefotiam dihydrochloride, which bears US NIH Compound Identifier 47896. Cefotiam dihydrochloride is the dihydrochloride salt of cefotiam.

UNSPSC 51283720 Cefotiam dihydrochloride is a Commodity code that does not match the work actually being solicited under it in recent state and local opportunities. The code nominally describes a specific antibiotic pharmaceutical product, yet the recent opportunities posted against this code span naloxone procurement, direct-to-manufacturer prescription programs, first-aid supplies for fire departments, and generic multi-source pharmaceutical contracting — none of which involve cefotiam dihydrochloride. This mismatch suggests either systematic miscoding in the source data or that the code is being used as a catch-all taxonomy marker for broader pharmaceutical and medical-supply purchasing activity rather than for the specific drug product its name denotes.

The recent opportunities show that state and local governments are buying emergency response medications (naloxone), general medical and first-aid consumables (gloves, bandaging, respiratory equipment, cardiac monitoring supplies), and generic pharmaceuticals through cooperative purchasing agreements and direct-to-manufacturer programs. Issuing bodies include county health departments (Seminole County, Florida), state health commissions (Texas Health and Human Services), municipal fire departments (Tampa Fire Department), and multistate cooperative purchasing organizations (Minnesota Multistate Cooperative Purchasing Alliance). Geographic activity spans Florida, Texas, Minnesota, and Oregon. Representative recent opportunities include Seminole County's IFB for naloxone and drug deactivation systems (due July 26, 2023), the City of Tampa's IFB for medical and first-aid supplies estimated at $700,000 (due March 13, 2026, with a 5 percent small-local-business discount), and MMCAP's RFP for generic pharmaceuticals and OTC products (due March 26, 2026). The code shows little relevant recent activity directly tied to cefotiam dihydrochloride; pursue this code only if your firm supplies pharmaceutical or medical-supply products more broadly and can absorb the coding inconsistency in your opportunity management.